Seribantumab companion diagnostic - MerrimackAlternative Names: MM 121 companion diagnostic; MM 121 companion diagsnotic - Leica Biosystems/Merrimack Pharmaceuticals; Seribantumab companion diagnostic - Leica Biosystems/Merrimack Pharmaceuticals
Latest Information Update: 23 May 2016
At a glance
- Originator Merrimack Pharmaceuticals
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Solid tumours